Groundbreaking study demonstrates that targeted oligodendrocyte gene therapy leads to decreased N-acetylaspartate (NAA) levels and increased ...
Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.
New study data showed treatment slowed signs of disease progression by 75% after three years, a finding that could have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback